Back to Search
Start Over
Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review
- Source :
- Gastroenterology. 158:930-946.e1
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Background & Aims Altering the intestinal microbiota has been proposed as a treatment for inflammatory bowel diseases (IBDs), but there are no established associations between specific microbes and IBD. We performed a systematic review to identify frequent associations. Methods We searched the MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials databases, through April 2, 2018 for studies that compared intestinal microbiota (from fecal or colonic or ileal tissue samples) among patients (adult or pediatric) with IBD vs healthy individuals (controls). The primary outcome was difference in specific taxa in fecal or intestinal tissue samples from patients with IBD vs controls. We used the Newcastle-Ottawa scale to assess the quality of studies included in the review. Results We identified 2631 citations; 48 studies from 45 articles were included in the analysis. Most studies evaluated adults with Crohn's disease or ulcerative colitis. All 3 studies of Christensenellaceae and Coriobacteriaceae and 6 of 11 studies of Faecalibacterium prausnitzii reported a decreased amount of those organisms compared with controls, whereas 2 studies each of Actinomyces, Veillonella, and Escherichia coli revealed an increased amount in patients with Crohn's disease. For patients with ulcerative colitis, Eubacterium rectale and Akkermansia were decreased in all 3 studies, whereas E coli was increased in 4 of 9 studies. The microbiota diversity was either decreased or not different in patients with IBD vs controls. Fewer than 50% of the studies stated comparable sexes and ages of cases and controls. Conclusions In a systematic review, we found evidence for differences in abundances of some bacteria in patients with IBD vs controls, but we cannot make conclusions due to inconsistent results and methods among studies. Further large-scale studies, with better methods of assessing microbe populations, are needed.
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Faecalibacterium prausnitzii
Gut flora
Gastroenterology
Inflammatory bowel disease
Feces
03 medical and health sciences
0302 clinical medicine
Crohn Disease
Internal medicine
medicine
Humans
Microbiome
Crohn's disease
Hepatology
biology
business.industry
Akkermansia
Inflammatory Bowel Diseases
biology.organism_classification
medicine.disease
Ulcerative colitis
digestive system diseases
Gastrointestinal Microbiome
3. Good health
Intestines
030104 developmental biology
Systematic review
Colitis, Ulcerative
030211 gastroenterology & hepatology
business
Subjects
Details
- ISSN :
- 00165085
- Volume :
- 158
- Database :
- OpenAIRE
- Journal :
- Gastroenterology
- Accession number :
- edsair.doi.dedup.....b6d193af496e6eb2afd71acbab50a9c5
- Full Text :
- https://doi.org/10.1053/j.gastro.2019.11.294